Triton Systems is developing several medical devices to treat ear-related issues and certain vestibular disorders to improve patient outcomes.

Intratympanic Drug Delivery

Inner-ear disorders, such as sensorineural hearing loss and tinnitus, are significant global public-health issues. Particularly when associated with acute noise or blast exposure, these disorders require timely intervention. However, local drug delivery to treat inner ear disorders requires clinical expertise and specialized instrumentation. Triton Systems is developing an intratympanic drug delivery device for minimally invasive treatments of inner-ear disorders. This system enables intratympanic administration of time-critical therapies in a safe and effective manner.

Real-Time Middle-Ear Mechanics Measurements

Reconstructive surgery has been quite successful in treating damage and disease in the middle ear, yet there is a wide variation in hearing outcomes. Very small variations in size and placement of prostheses result in large differences in hearing outcomes, and a quantitative understanding is generally lacking. Triton Systems is developing a medical device to provide real-time analysis of middle-ear mechanics, help determine ossicular mobility and appropriate lengths of ossicular prostheses, and measure the tension on the repaired tympanic membrane intraoperatively. This handheld surgical tool will assist surgeons performing tympanomastoid surgery and will aim to improve post-operative hearing results.

Galvanic Vestibular Simulator

Vestibular impairment such as dizziness and nausea following traumatic brain injury (TBI) or other general balance disorders afflicts millions of people, and only very limited treatment options are available. Triton Systems is developing the NanoStim galvanic vestibular stimulator, a breakthrough device to relieve vestibular symptoms. NanoStim is the first galvanic vestibular stimulator that is truly wearable and can provide effective vestibular treatment that is simple, safe, and noninvasive. The NanoStim can have a far-reaching impact on treating vestibular dysfunction by significantly improving patient outcomes.